Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VBL Plc Board/Management Information 2022

Mar 1, 2022

2060_rns_2022-03-01_1a8bc1a5-380b-426a-8739-eeeec159a4d9.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

VBL Plc (C56012)

("the Company")

COMPANY ANNOUNCEMENT

Resignation and Appointment of Secretary

Date: 01st March 2022 Ref. VBL1/2022

This is a company announcement made by the Company in compliance with the Capital Markets Rules.

The Company announces that Dr. David Meli has resigned from the position of Company Secretary with effect from 1st March 2022. There is no matter concerning Dr. Meli's resignation that warrants any disclosure in terms of the Capital Markets Rules.

The Board of Directors would like to thank Dr. Meli for his loyalty and commitment to the Company for the past years of service as Company Secretary, particularly during the IPO process. Pursuant to the foregoing, the Company further announces that Dr. Joe Borg Bartolo and Dr. Mikiel Calleja have been appointed as company secretaries with effect from the same date. In accordance with Capital Markets Rule 5.20, the following details are hereby being provided to the public:

Name Dr. Joe Borg Bartolo
Address 8, Casa San Lawrenz, Triq I-Gholja ta San Lawrenz, Siggiewi,
Malta
Function Company Secretary
Principal activities outside the N/A
Company
Current
and
past
(Syears)
Merill SICAV p.l.c. (current)
directorships: Luxury Living Finance p.l.c. (resigned 30th October 2020)
Other disclosures There are no disclosures to be made in terms of Capital
Markets Rules 5.20.5 to 5.20.9 (both included)
Name Dr. Mikiel Calleia
Address 3, Highbury Court, Triq ir-Ratal, Swieqi, Malta
Function Company Secretary
Principal activities outside the N/A
Company
Current
and past
(5years)
N/A
directorships:
Other disclosures There are no disclosures to be made in terms of Capital
Markets Rules 5.20.5 to 5.20.9 (both included)
S

Dr Mikiel Calleja

Company Secretary

C